Register for our free email digests:
Francesca Bruce
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Francesca Bruce
Scotland Greenlights More Rare Disease Treatments
Scotland’s health technology appraisal body has OKd Alynlam’s Onpattro, AstraZeneca's Imfinzi and Takeda’s Alunbrig for use on the Scottish National Health Service.
Compulsory License On Table In UK For Orkambi
The UK government will consider all options to improve access to Vertex’s cystic fibrosis treatment, including compulsory licensing.
Canada Moves To Boost Biosimilar Market
Biosimilar uptake in Canada is expected to benefit from moves to switch patients onto biosimilars and the removal of health technology appraisal reviews from the process for listing drugs on public plans.
UK Buyers Club Aims For Lower-Cost Cystic Fibrosis Drugs
A buyers club in the UK is planning to import generic versions of Vertex’s cystic fibrosis drugs that are not available on the NHS. Some commentators think such clubs may become more common.
Argentina Joins International Pharmaceutical Regulators Programme
Argentina’s drug regulator has become the newest member of the International Pharmaceutical Regulators Programme.
UK Buyers Club To Get Lower Cost Versions Of Vertex’s CF Drugs
A buyers club in the UK is planning to import generic versions of Vertex’s cystic fibrosis drugs that are not available on the NHS. Some commentators think such clubs may become more common.